(Q50667123)

17 March 2018

title

Cost-effectiveness analysis with defined budget: how to distribute resources for the prevention of cardiovascular disease? (English)

1 reference

17 March 2018

main subject

cardiovascular disease

1 reference

5

1 reference

17 March 2018

author name string

Lindholm L

1

1 reference

17 March 2018

Hallgren CG

2

1 reference

17 March 2018

Boman K

3

1 reference

17 March 2018

Markgren K

4

1 reference

17 March 2018

Ogren JE

6

1 reference

17 March 2018

publication date

1 September 1999

1 reference

17 March 2018

published in

Health Policy

1 reference

17 March 2018

volume

48

1 reference

17 March 2018

issue

3

1 reference

17 March 2018

page(s)

155-170

1 reference

17 March 2018

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

1 reference

7 January 2021

Principles of cost-effective resource allocation in health care organizations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

On the decision rules of cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

Reporting guidelines for economic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

Some guidelines on the use of cost effectiveness league tables

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

Changing the problem to fit the solution: Johannesson and Weinstein's (mis) application of economics to real world problems.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

QALY league tables: handle with care

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

Cost-effectiveness analysis: is it ethical?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

Some factors to consider when using the results of economic evaluation studies at the population level.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2899%2900045-7

7 January 2021

10.1016/S0168-8510(99)00045-7

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018